Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02377947
What this trial is testing

A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]

Who this might be right for
Hepatic Encephalopathy
Abbott 50
Testing effectiveness (Phase 2)UnknownNCT00989352
What this trial is testing

Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma

Who this might be right for
Primary Non Hodgkin Lymphoma of the Central Nervous System
University Hospital Freiburg 56
Testing effectiveness (Phase 2)Ended earlyNCT06561425
What this trial is testing

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Lakefront Biotherapeutics NV 130
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Not applicableStudy completedNCT00416819
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Testing effectiveness (Phase 2)Ended earlyNCT00072449
What this trial is testing

Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableStudy completedNCT03692988
What this trial is testing

Dignity Therapy for Patients With Early Dementia and Their Family

Who this might be right for
Dementia, MildDepressive Disorder
University of Zurich 54
Testing effectiveness (Phase 2)Looking for participantsNCT04906096
What this trial is testing

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

Who this might be right for
Primary Central Nervous System LymphomaNon-Hodgkin Lymphoma of Extranodal Site
Lakshmi Nayak, MD 25
Not applicableStudy completedNCT03188354
What this trial is testing

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinCentral Nervous System Neoplasms
Norwegian University of Science and Technology 3
Not applicableStudy completedNCT00082836
What this trial is testing

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Study completedNCT03495960
What this trial is testing

Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System

Who this might be right for
Primary Central Nervous System Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 72
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableUnknownNCT06455163
What this trial is testing

Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers

Who this might be right for
Dementia, Mild
VU University of Amsterdam 102
Not applicableStudy completedNCT00416312
What this trial is testing

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Very early researchLooking for participantsNCT04532203
What this trial is testing

CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
Zhejiang University 72
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT06362707
What this trial is testing

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Who this might be right for
Cognitive Decline, MildAlzheimer Disease
Helse Stavanger HF 200
Next Page